Form 4: Accendra Health Director Acquires Shares
Statement of Changes in Beneficial Ownership
Director Kenneth Gardner-Smith acquired 31,191 shares of common stock in Accendra Health, Inc. on May 14, 2026.
Summary
- Kenneth Gardner-Smith, a Director at Accendra Health, Inc., acquired 31,191 shares of common stock on May 14, 2026.
- This acquisition was made at a price of $0 per share, indicating it was likely a grant or award.
- Following this transaction, Gardner-Smith beneficially owns 86,113 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a director acquiring shares, which can signal confidence, but provides no new financial or strategic information.
Positives
- Director acquisition of shares can signal confidence in the company's future prospects.
- The acquisition of a significant number of shares (31,191) by a director may be viewed positively by the market.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it is a statement of changes in beneficial ownership.
Industry Context
StockSavvy.ai notes that insider stock acquisitions by directors are common disclosures and can be interpreted as a positive signal of management's belief in the company's value, though the specifics of the transaction (e.g., grant vs. purchase) are crucial for a complete assessment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rule 10b5-1 Plan | The filing notes the possibility that the transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | Not specified, but implied to be prior to the transaction date. | Indicates potential pre-planned trading activity, which can reduce concerns about insider trading based on material non-public information. |
| Restricted Stock Grant Vesting | The acquired shares are described as a restricted stock grant that vests either one year from the grant date or on the date of the next annual meeting, whichever is earlier. The grant date is not explicitly stated but implied to be prior to the transaction date. | Vesting occurs on the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. | This outlines the conditions under which the director will gain full ownership of the granted shares, impacting future beneficial ownership. |
Stakeholder Impact
- Shareholders: May view the director's acquisition positively as a sign of commitment and confidence in the company's future.
- Management: Reinforces the alignment of interests between directors and shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Transaction Date for acquisition of common stock by Kenneth Gardner-Smith. |
| 05/18/2026 | Signature Date of the filing. |
Keywords
Accendra Health, Form 4, Insider Trading, Director, Stock Acquisition, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.